{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:43:35Z","timestamp":1698475415341},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":4368,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1997,9,10]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold> In order to elucidate the mechanism(s) behind the interactions between barbiturates and Ca<jats:sup>2+<\/jats:sup> antagonists, the effects of pentobarbital combined with three structurally diverse types of Ca<jats:sup>2+<\/jats:sup> antagonist on CaCl<jats:sub>2<\/jats:sub>\u2010induced contractile responses of the guinea pig thoracic aorta in Ca<jats:sup>2+<\/jats:sup>\u2010free and 40 mM K<jats:sup>+<\/jats:sup> medium and the effects of pentobarbital on Ca<jats:sup>2+<\/jats:sup> antagonist binding to guinea pig aortic membranes were investigated. The dihydropyridine derivatives isradipine (10<jats:sup>\u221210<\/jats:sup>\u201310<jats:sup>\u22128<\/jats:sup> M) and nifedipine (10<jats:sup>\u221210\u2013<\/jats:sup>10<jats:sup>\u22128<\/jats:sup> M) inhibited CaCl<jats:sub>2<\/jats:sub>\u2010induced contractions concentration\u2010dependently. Treatment with both pentobarbital (10<jats:sup>\u22124<\/jats:sup> M) and dihydropyridine Ca<jats:sup>2+<\/jats:sup> antagonists (10<jats:sup>\u22129<\/jats:sup> M) shifted the CaCl<jats:sub>2<\/jats:sub> concentration\u2010response curves to the right significantly compared with those after treatment with the Ca<jats:sup>2+<\/jats:sup> antagonists and pentobarbital alone. However, no synergistic effects of pentobarbital (10<jats:sup>\u22124<\/jats:sup> M) with other types of Ca<jats:sup>2+<\/jats:sup> antagonist (verapamil (10<jats:sup>\u22127<\/jats:sup> M) and diltiazem (10<jats:sup>\u22126<\/jats:sup> M)) were observed. The binding of [<jats:sup>3<\/jats:sup>H]isradipine (2 \u00d7 10<jats:sup>\u22129<\/jats:sup> M) to guinea pig aortic membranes was increased significantly by simultaneous pentobarbital treatment, but no such effect was observed with [<jats:sup>3<\/jats:sup>H]verapamil (10<jats:sup>\u22128<\/jats:sup> M) or [<jats:sup>3<\/jats:sup>H]diltiazem (2 \u00d7 10<jats:sup>\u22128<\/jats:sup> M). These findings suggest that the synergistic contractile effects of pentobarbital and dihydropyridines were, in part, due to enhancement of dihydropyridine binding to guinea pig aortic membranes (L\u2010type Ca<jats:sup>2+<\/jats:sup> channels) by pentobarbital and that the interactions between pentobarbital and Ca<jats:sup>2+<\/jats:sup> antagonists may be structurally specific.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1997.tb00207.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:24:22Z","timestamp":1251307462000},"page":"448-453","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic actions of pentobarbital and dihydropyridine Ca<sup>2+<\/sup> antagonists on guinea pig isolated thoracic aorta\u2020"],"prefix":"10.1111","volume":"11","author":[{"given":"T.","family":"Inami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kotake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1987.sp016861"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1152\/ajplegacy.1975.229.6.1635","article-title":"Pentobarbital and contraction of vascular smooth muscle","volume":"229","author":"Altura BT","year":"1975","journal-title":"Am J Physiol"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(80)90093-0"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/S0021-9258(18)68955-0","article-title":"Molecular properties of dihydropyridine\u2010sensitive calcium channels in skeletal muscle","volume":"263","author":"Catterall WA","year":"1988","journal-title":"J Biol Chem"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb16265.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(08)60695-0"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0031018"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1981.tb13803.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1990.tb03138.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5033-0_3"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11646.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb16878.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(85)90006-0"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)91083-3"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)91179-3"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)88977-4"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03008328"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1997.tb00207.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1997.tb00207.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:50:41Z","timestamp":1698411041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1997.tb00207.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,9,10]]}},"alternative-id":["10.1111\/j.1472-8206.1997.tb00207.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1997.tb00207.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9,10]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}